• 1

Find the latest funding information here.

  • 03/09/2019

    NEW

    Allecra Therapeutics to Present Data at ASM/ESCMID 2019 Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Download PDF
  • 22/08/2018
    Allecra Therapeutics successfully enters next development phase
    Download PDF
  • 17/04/2018
    Allecra Therapeutics to present data at 28th European Congress of Clinical Microbiology and Infectious Diseases
    Download PDF
  • 26/03/2018
    Allecra Therapeutics announces Positive Top-Line Results from Phase 2 CACTUS Study of its Lead Candidate, Enmetazobactam, in Combination with Cefepime to treat complicated Urinary Tract Infections (cUTI)
    Download PDF
  • 03/04/2018
    Allecra Therapeutics announces participation at the H.C. Wainwright annual global life sciences conference in Monte Carlo, Monaco on April 8-10,2018
    Download PDF
  • 04/05/2017
    Allecra Therapeutics Strengthens Leadership Team with Appointment of New Chairman and Chief Medical Officer
    Download PDF
  • 4/12/2017
    Allecra Therapeutics Announces New Staged Financing Deal to Take the Company Through to End of Phase 3
    Download PDF
  • 06/04/2016
    Allecra Therapeutics Announces €22 Million Series B Financing
    Download PDF
  • 1

Home

Antibiotic Resistance  

About us

ALLECRA Team
Advisory Board
Scientific Advisory Board
Join us    

Antimicrobial Resistance

 

Investors

Press Releases

Scientific Information

Journal Publications

Conference Poster  

Contact

Allecra Therapeutics GmbH
Im Kränzliacker 9
79576 Weil am Rhein
Germany
 

Allecra Therapeutics SAS
10 rue Alexandre Freund
68300 Saint-Louis France
Tel +33 3 8968 9876

Mail

IR@allecra.com
If you have any questions about our work,
please feel free to contact us.

All rights reserved
Copyright 2018
Allecra Therapeutics SAS